SARS-CoV-2'nin Olasi Noroinvazyon Mekanizmalari

被引:1
|
作者
Sahin, Ali [1 ]
Korkunc, Seval Kubra [2 ]
Kurtoglu, Fatima Hacer [3 ]
Taskiran, Hilal [3 ]
Ekmekci, Betigul [4 ]
Babayev, Huseyn [1 ]
Ekmekci, Ahmet Hakan [5 ]
机构
[1] Selcuk Univ, Fac Med, Konya, Turkey
[2] Koc Univ, Inst Hlth Sci, Dept Immunol, Istanbul, Turkey
[3] Koc Univ, Inst Hlth Sci, Dept Cellular & Mol Med, Istanbul, Turkey
[4] Bahcesehir Univ, Fac Med, Istanbul, Turkey
[5] Selcuk Univ, Fac Med, Dept Neurol, Konya, Turkey
来源
TURKISH JOURNAL OF IMMUNOLOGY | 2022年 / 10卷 / 02期
关键词
SARS-CoV-2; antiviral immunity; neurology; neuroinvasion; COVID-19; ACUTE RESPIRATORY SYNDROME; T-CELL RESPONSES; SARS CORONAVIRUS; NEUROLOGICAL MANIFESTATIONS; LYMPHATIC DRAINAGE; IMMUNE-RESPONSE; CEREBRAL EDEMA; COVID-19; INFECTION; SYSTEM;
D O I
10.4274/tji.galenos.2022.80774
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The severe acute respiratory syndrome coronavirus-2, a coronavirus, is known to cause acute respiratory distress syndrome and a range of nonrespiratory effects, particularly in elderly male patients with underlying health conditions such overweight, diabetes, and hypertension. The coronavirus disease-2019 sequelae include multiple organ failure and neurological issues, and these prior health issues are linked to endothelial dysfunction. Although inhalation is the most frequent mode of infection, this virus has also been discovered in neurons, cerebrospinal fluid, the choroid plexus, and meningeal vasculature.
引用
收藏
页码:69 / 76
页数:8
相关论文
共 50 条
  • [31] A comprehensive review about SARS-CoV-2
    Haque, S. K. Manirul
    Ashwaq, Omar
    Sarief, Abdulla
    Azad John Mohamed, Abdul Kalam
    FUTURE VIROLOGY, 2020, 15 (09) : 625 - 648
  • [32] Superantigens and SARS-CoV-2
    Hamdy, Adam
    Leonardi, Anthony
    PATHOGENS, 2022, 11 (04):
  • [33] SARS-CoV-2: is there neuroinvasion?
    McQuaid, Conor
    Brady, Molly
    Deane, Rashid
    FLUIDS AND BARRIERS OF THE CNS, 2021, 18 (01)
  • [34] The evolution of SARS-CoV-2
    Markov, Peter V.
    Ghafari, Mahan
    Beer, Martin
    Lythgoe, Katrina
    Simmonds, Peter
    Stilianakis, Nikolaos I.
    Katzourakis, Aris
    NATURE REVIEWS MICROBIOLOGY, 2023, 21 (06) : 361 - 379
  • [35] miRNAs in SARS-CoV-2 Infection: An Update
    Azhar, Asim
    Khan, Wajihul Hasan
    Al-Hosaini, Khaled
    Kamal, Mohammad Amjad
    CURRENT DRUG METABOLISM, 2022, 23 (04) : 283 - 298
  • [36] Inhibition of SARS-CoV-2 by type I and type III interferons
    Felgenhauer, Ulrike
    Schoen, Andreas
    Gad, Hans Henrik
    Hartmann, Rune
    Schaubmar, Andreas R.
    Failing, Klaus
    Drosten, Christian
    Weber, Friedemann
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (41) : 13958 - 13964
  • [37] Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2
    Iroegbu, Joy D.
    Ifenatuoha, Chibuzor W.
    Ijomone, Omamuyovwi M.
    NEUROLOGICAL SCIENCES, 2020, 41 (06) : 1329 - 1337
  • [38] Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS
    Rokni, Mohsen
    Ghasemi, Vida
    Tavakoli, Zahra
    REVIEWS IN MEDICAL VIROLOGY, 2020, 30 (03)
  • [39] SARS-CoV-2 infection and cancer Evidence for and against a role of SARS-CoV-2 in cancer onset
    Stingi, Aureliano
    Cirillo, Luca
    BIOESSAYS, 2021, 43 (08)
  • [40] Adaptive immune responses to SARS-CoV-2 q
    Forthal, Donald
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 172 : 1 - 8